acetylcysteine has been researched along with Pulmonary Sarcoidosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barkes, B; Canono, B; Day, B; Gillespie, M; Hamzeh, N; Huang, J; Li, L; Maier, L | 1 |
| Lota, HK; Wells, AU | 1 |
1 review(s) available for acetylcysteine and Pulmonary Sarcoidosis
| Article | Year |
|---|---|
The evolving pharmacotherapy of pulmonary fibrosis.
Topics: Acetylcysteine; Anti-Inflammatory Agents, Non-Steroidal; Humans; Idiopathic Interstitial Pneumonias; Immunosuppressive Agents; Indoles; Lung Diseases, Interstitial; Pulmonary Fibrosis; Pyridones; Randomized Controlled Trials as Topic; Sarcoidosis, Pulmonary; Scleroderma, Systemic; Treatment Outcome | 2013 |
1 trial(s) available for acetylcysteine and Pulmonary Sarcoidosis
| Article | Year |
|---|---|
The effect of an oral anti-oxidant, N-Acetyl-cysteine, on inflammatory and oxidative markers in pulmonary sarcoidosis.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acetylcysteine; Administration, Oral; Adult; Aged; Antioxidants; Bronchoalveolar Lavage Fluid; Deoxyguanosine; DNA; Double-Blind Method; Female; Glutathione; Humans; Inflammation; Lipopolysaccharides; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress; Sarcoidosis, Pulmonary; Tumor Necrosis Factor-alpha | 2016 |